The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancer.

Enwere, Emeka K; Dean, Michelle L; Li, Haocheng; D'Silva, Adrijana; Bebb, D Gwyn

Enwere, Emeka K; Dean, Michelle L; Li, Haocheng; D'Silva, Adrijana; Bebb, D Gwyn.

Afiliación

Enwere EK; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Dean ML; Translational Laboratories, Tom Baker Cancer Center, Calgary, Alberta, Canada.
Li H; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
D'Silva A; Department of Oncology, Tom Baker Cancer Center, Calgary, Alberta, Canada.
Bebb DG; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Transl Lung Cancer Res ; 9(3): 496-506, 2020 Jun.

Article en En | MEDLINE | ID: mdl-32676313

Palabras clave

Estrogen receptor (ER); image analysis; immunohistochemistry; non-small cell lung cancer (NSCLC)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Lung Cancer Res Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google